GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » Aveo Healthcare Ltd (ASX:AEH) » Definitions » YoY EBITDA Growth

Aveo Healthcare (ASX:AEH) YoY EBITDA Growth : 13.43% (As of Dec. 2013)


View and export this data going back to . Start your Free Trial

What is Aveo Healthcare YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Aveo Healthcare's YoY EBITDA Growth for the quarter that ended in Dec. 2013 was 13.43%.

Aveo Healthcare's EBITDA per Share for the six months ended in Dec. 2013 was A$-0.06.


Aveo Healthcare YoY EBITDA Growth Historical Data

The historical data trend for Aveo Healthcare's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aveo Healthcare YoY EBITDA Growth Chart

Aveo Healthcare Annual Data
Trend Jun04 Jun05 Jun06 Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -80.61 199.07 108.05 -212.35 94.57

Aveo Healthcare Semi-Annual Data
Jun04 Dec04 Jun05 Dec05 Jun06 Dec06 Jun07 Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -40.35 -228.29 -297.06 103.30 13.43

Aveo Healthcare YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Aveo Healthcare's YoY EBITDA Growth for the fiscal year that ended in Jun. 2013 is calculated as:

YoY EBITDA Growth (A: Jun. 2013 )
=(EBITDA per Share (A: Jun. 2013 )-EBITDA per Share (A: Jun. 2012 ))/ | EBITDA per Share (A: Jun. 2012 ) |
=(-0.041--0.755)/ | -0.755 |
=94.57 %

Aveo Healthcare's YoY EBITDA Growth for the quarter that ended in Dec. 2013 is calculated as:

YoY EBITDA Growth (Q: Dec. 2013 )
=(EBITDA per Share (Q: Dec. 2013 )-EBITDA per Share (Q: Dec. 2012 )) / | EBITDA per Share (Q: Dec. 2012 )) |
=(-0.058--0.067)/ | -0.067 |
=13.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aveo Healthcare YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Aveo Healthcare's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Aveo Healthcare (ASX:AEH) Business Description

Traded in Other Exchanges
N/A
Address
Aveo Healthcare Ltd provides retirement communities in South-East Queensland. The Company's healthcare's portfolio comprises five retirement villages, located in Albany Creet, Clayfield, Cleveland, Durack and Taringa.

Aveo Healthcare (ASX:AEH) Headlines

From GuruFocus

Aegon NV Stock Shows Every Sign Of Being Fairly Valued

By GF Value GF Value 04-23-2021

Aegon AM adds three to Responsible Investment team

By PRNewswire PRNewswire 10-13-2021

Allegra van H�vell-Patrizi appointed CEO of Aegon the Netherlands

By Business Wire Business Wire 06-15-2021

Aegon Bank has set up an additional Covered Bond Program

By Business Wire Business Wire 05-10-2021

Aegon Asset Management closes first deal in ESG-centric venture

By PRNewswire PRNewswire 05-26-2022

AM Best Affirms Credit Ratings of Aegon N.V.'s U.S. Subsidiaries

By Business Wire Business Wire 11-03-2022

Aegon completes share buyback program

By Business Wire Business Wire 08-23-2021

Aegon Asset Management closes first deal in ESG-centric venture

By PRNewswire PRNewswire 07-05-2022